Overview
Dr. Gorden believes in tailoring care to the individual patient needs and finding therapeutic options for patients with all stages of disease.
Dr. Gorden is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Pleural Effusion, Empyema, Lung Cancer, and Squamous Cell Lung Carcinoma.
His clinical research consists of co-authoring 54 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles and participated in 1 clinical trial in the study of Non-Small Cell Lung Cancer (NSCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1101 Madison Street, Suite 900, Seattle, WA 98104
500 17th Avenue, Seattle, WA 98122
747 Broadway, Seattle, WA 98122
Additional Areas of Focus
Dr. Gorden has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Virginia Mason Medical Center
Misho Hubka, MD, is a board-certified thoracic surgeon. His special medical interests include Robotic and Video-Assisted Thoracoscopic Surgery (VATS), lung cancer surgery, esophageal cancer surgery, and complex surgery for benign and malignant disease of the lung, chest wall, esophagus and mediastinum.Dr. Hubka is a member of the Society of Thoracic Surgeons, STS Patient Safety Workforce and Western Thoracic Surgical Association. He was named a Top Doctor by Seattle Met Magazine in 2017, 2018 and 2019. Dr. Hubka is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Hiatal Hernia, Hernia, Neuroendocrine Tumor, Gastrostomy, and Endoscopy.
Eric Vallieres is a Thoracic Surgeon in Seattle, Washington. Dr. Vallieres is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleural Effusion, Thymectomy, and Endoscopy. Dr. Vallieres is currently accepting new patients.
Virginia Mason Medical Center
Steven Kirtland is an Intensive Care Medicine provider in Seattle, Washington. Dr. Kirtland is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Nodules, Acute Interstitial Pneumonia, Lung Metastases, Hypersensitivity Pneumonitis, and Advanced Bronchoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pleural EffusionDr. Gorden isElite. Learn about Pleural Effusion.
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Gorden isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EmpyemaDr. Gorden isDistinguished. Learn about Empyema.
- Lung CancerDr. Gorden isDistinguished. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)Dr. Gorden isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Gorden isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- EGFR Positive Lung CancerDr. Gorden isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Gorden isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Gorden isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acquired TracheomalaciaDr. Gorden isExperienced. Learn about Acquired Tracheomalacia.
- Cerebral HypoxiaDr. Gorden isExperienced. Learn about Cerebral Hypoxia.
- Lung NodulesDr. Gorden isExperienced. Learn about Lung Nodules.
- Parapneumonic Pleural EffusionDr. Gorden isExperienced. Learn about Parapneumonic Pleural Effusion.
- PleurisyDr. Gorden isExperienced. Learn about Pleurisy.
- Pulmonary Alveolar ProteinosisDr. Gorden isExperienced. Learn about Pulmonary Alveolar Proteinosis.